Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Announces Preliminary Second Quarter Revenue Results; Will Host Second Quarter 2020 Financial Results Conference Call on August 10, 2020
PRINCETON, N.J., July 09, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today certain unaudited preliminary second quarter financial results. The company also announced that it will release full second
View HTML
Toggle Summary Integra LifeSciences Announces Key Executive Leadership Changes
PRINCETON, N.J., May 21, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced changes to its executive leadership team. Michael McBreen, who is currently the corporate vice president and president of the international business, has been promoted to
View HTML
Toggle Summary Integra LifeSciences Announces Positive Clinical Results for Integra® Bilayer Wound Matrix (IBWM)
Data Shows IBWM Reduced Operating Room Time and Costs Associated with Lower Extremity Wounds PRINCETON, N.J., May 15, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, today announced positive clinical and economic data on
View HTML
Toggle Summary Integra LifeSciences Announces May 2020 Investor Conference Schedule
PRINCETON, N.J., May 11, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it will participate in two investor conferences in May. On May 12, 2020, Glenn Coleman, chief operating officer will present
View HTML
Toggle Summary Integra LifeSciences Reports First Quarter 2020 Financial Results
PRINCETON, N.J., May 07, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2020. First Quarter 2020 Financial Summary Reported revenues were $354.3
View HTML
Toggle Summary Integra LifeSciences Holdings Corporation Announces Virtual-Only Format for Its 2020 Annual Meeting of Stockholders
PRINCETON, N.J., April 23, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that its 2020 Annual Meeting of Stockholders (the “Meeting”) location will change from its headquarters to a virtual meeting by
View HTML
Toggle Summary Integra LifeSciences Announces Preliminary First Quarter Revenue Results and Provides an Update on COVID-19 Impact; Will Host First Quarter 2020 Financial Results Conference Call on May 7, 2020
PRINCETON, N.J., April 07, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today certain unaudited preliminary first quarter financial results.  The company also announced that it will release full first
View HTML
Toggle Summary Integra LifeSciences Launches AmnioExcel® Plus Placental Allograft Membrane
The Next Generation in Amniotic Tissue Products PRINCETON, N.J. , Feb. 24, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq:IART), a leading global medical technology company, today announced the launch of AmnioExcel ® Plus Placental Allograft Membrane, its latest wound
View HTML
Toggle Summary Integra LifeSciences Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides 2020 Financial Guidance
PRINCETON, N.J., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2019 and issued its financial guidance for 2020, consistent with the preliminary results and guidance
View HTML
Toggle Summary Integra LifeSciences to Host Fourth Quarter and Full-Year 2019 Financial Results Conference Call on February 19, 2020
PRINCETON, N.J., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full-year 2019 financial results on Wednesday, February 19, 2020 prior to market open.
View HTML
Toggle Summary Integra Announces Pricing of Convertible Senior Notes
PRINCETON, N.J., Feb. 04, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced the pricing of $500,000,000 aggregate principal amount of 0.5% convertible senior notes due 2025 (the “Notes”). The Notes were offered and sold in a private placement solely to
View HTML
Toggle Summary Integra Announces Amendment and Extension of Credit Facility and Private Placement of Convertible Senior Notes
PRINCETON, N.J., Feb. 03, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has amended and extended its credit facility and commenced a private offering of convertible senior notes. Amendment and Extension of Credit Facility Integra today
View HTML
Toggle Summary Integra LifeSciences Announces Preliminary Fourth Quarter and Full-Year 2019 Revenue Results and 2020 Financial Guidance
Fourth quarter 2019 reported revenue is expected to be at or near the low end of the previously communicated guidance range of $395 to $400 million, representing organic revenue growth of slightly less than 5% and reported growth of approximately 3%; For the full-year 2020, the company is providing
View HTML
Toggle Summary Integra LifeSciences to Present at the 38th Annual J.P. Morgan Healthcare Conference
PLAINSBORO, N.J., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced President and Chief Executive Officer Peter Arduini will speak at the 38 th Annual J.P.
View HTML
Toggle Summary Integra LifeSciences to participate in the Piper Jaffray 31st Annual Healthcare Conference
PRINCETON, N.J., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Carrie Anderson, chief financial officer, will present at the Piper Jaffray 31 st Annual Healthcare Conference in New York
View HTML